Creative Biolabs-Immuno-oncology

Anti-FLT1 (clone 2E5LG9Q) SynExpress C-Cy2-cJ-H Modified CD8+ T cells (CAT#: ITS-1224-CR369)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FLT1 (clone 2E5LG9Q). We employs the HBV (CMV-Cy2-c-Jun-HindIII) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
FLT1
Clone
2E5LG9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
CMV
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.97
Cell Culture
Aseptic Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.